Global Gastrointestinal Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 89468
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Gastrointestinal Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Gastrointestinal Therapeutics size is estimated to be USD 42810 million in 2026 from USD 35120 million in 2020, with a change XX% between 2020 and 2021. The global Gastrointestinal Therapeutics market size is expected to grow at a CAGR of 5.1% for the next five years.

Market segmentation

Gastrointestinal Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Oral

Parenteral

Market segment by Application, can be divided into

IBD

Irritable Bowel Syndrome (IBS)

Market segment by players, this report covers

AbbVie

Allergan

Johnson & Johnson

Takeda

Novartis

Pfizer

Merck

F. Hoffmann-La Roche

Eli Lilly

AstraZeneca

Procter & Gamble

Tillotts Pharma

Takeda

GlaxoSmithKline

Amgen

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Gastrointestinal Therapeutics product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Gastrointestinal Therapeutics, with revenue, gross margin and global market share of Gastrointestinal Therapeutics from 2019 to 2021.

Chapter 3, the Gastrointestinal Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Gastrointestinal Therapeutics market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Gastrointestinal Therapeutics research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Gastrointestinal Therapeutics

1.2 Classification of Gastrointestinal Therapeutics by Type

1.2.1 Overview: Global Gastrointestinal Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Gastrointestinal Therapeutics Revenue Market Share by Type in 2020

1.2.3 Oral

1.2.4 Parenteral

1.3 Global Gastrointestinal Therapeutics Market by Application

1.3.1 Overview: Global Gastrointestinal Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 IBD

1.3.3 Irritable Bowel Syndrome (IBS)

1.4 Global Gastrointestinal Therapeutics Market Size & Forecast

1.5 Global Gastrointestinal Therapeutics Market Size and Forecast by Region

1.5.1 Global Gastrointestinal Therapeutics Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Gastrointestinal Therapeutics Market Size by Region, (2016-2021)

1.5.3 North America Gastrointestinal Therapeutics Market Size and Prospect (2016-2026)

1.5.4 Europe Gastrointestinal Therapeutics Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Gastrointestinal Therapeutics Market Size and Prospect (2016-2026)

1.5.6 South America Gastrointestinal Therapeutics Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Gastrointestinal Therapeutics Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Gastrointestinal Therapeutics Market Drivers

1.6.2 Gastrointestinal Therapeutics Market Restraints

1.6.3 Gastrointestinal Therapeutics Trends Analysis

2 Company Profiles

2.1 AbbVie

2.1.1 AbbVie Details

2.1.2 AbbVie Major Business

2.1.3 AbbVie Gastrointestinal Therapeutics Product and Solutions

2.1.4 AbbVie Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 AbbVie Recent Developments and Future Plans

2.2 Allergan

2.2.1 Allergan Details

2.2.2 Allergan Major Business

2.2.3 Allergan Gastrointestinal Therapeutics Product and Solutions

2.2.4 Allergan Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Allergan Recent Developments and Future Plans

2.3 Johnson & Johnson

2.3.1 Johnson & Johnson Details

2.3.2 Johnson & Johnson Major Business

2.3.3 Johnson & Johnson Gastrointestinal Therapeutics Product and Solutions

2.3.4 Johnson & Johnson Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Johnson & Johnson Recent Developments and Future Plans

2.4 Takeda

2.4.1 Takeda Details

2.4.2 Takeda Major Business

2.4.3 Takeda Gastrointestinal Therapeutics Product and Solutions

2.4.4 Takeda Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Takeda Recent Developments and Future Plans

2.5 Novartis

2.5.1 Novartis Details

2.5.2 Novartis Major Business

2.5.3 Novartis Gastrointestinal Therapeutics Product and Solutions

2.5.4 Novartis Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Novartis Recent Developments and Future Plans

2.6 Pfizer

2.6.1 Pfizer Details

2.6.2 Pfizer Major Business

2.6.3 Pfizer Gastrointestinal Therapeutics Product and Solutions

2.6.4 Pfizer Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Pfizer Recent Developments and Future Plans

2.7 Merck

2.7.1 Merck Details

2.7.2 Merck Major Business

2.7.3 Merck Gastrointestinal Therapeutics Product and Solutions

2.7.4 Merck Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Merck Recent Developments and Future Plans

2.8 F. Hoffmann-La Roche

2.8.1 F. Hoffmann-La Roche Details

2.8.2 F. Hoffmann-La Roche Major Business

2.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Product and Solutions

2.8.4 F. Hoffmann-La Roche Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 F. Hoffmann-La Roche Recent Developments and Future Plans

2.9 Eli Lilly

2.9.1 Eli Lilly Details

2.9.2 Eli Lilly Major Business

2.9.3 Eli Lilly Gastrointestinal Therapeutics Product and Solutions

2.9.4 Eli Lilly Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Eli Lilly Recent Developments and Future Plans

2.10 AstraZeneca

2.10.1 AstraZeneca Details

2.10.2 AstraZeneca Major Business

2.10.3 AstraZeneca Gastrointestinal Therapeutics Product and Solutions

2.10.4 AstraZeneca Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 AstraZeneca Recent Developments and Future Plans

2.11 Procter & Gamble

2.11.1 Procter & Gamble Details

2.11.2 Procter & Gamble Major Business

2.11.3 Procter & Gamble Gastrointestinal Therapeutics Product and Solutions

2.11.4 Procter & Gamble Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Procter & Gamble Recent Developments and Future Plans

2.12 Tillotts Pharma

2.12.1 Tillotts Pharma Details

2.12.2 Tillotts Pharma Major Business

2.12.3 Tillotts Pharma Gastrointestinal Therapeutics Product and Solutions

2.12.4 Tillotts Pharma Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Tillotts Pharma Recent Developments and Future Plans

2.13 Takeda

2.13.1 Takeda Details

2.13.2 Takeda Major Business

2.13.3 Takeda Gastrointestinal Therapeutics Product and Solutions

2.13.4 Takeda Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Takeda Recent Developments and Future Plans

2.14 GlaxoSmithKline

2.14.1 GlaxoSmithKline Details

2.14.2 GlaxoSmithKline Major Business

2.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Product and Solutions

2.14.4 GlaxoSmithKline Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 GlaxoSmithKline Recent Developments and Future Plans

2.15 Amgen

2.15.1 Amgen Details

2.15.2 Amgen Major Business

2.15.3 Amgen Gastrointestinal Therapeutics Product and Solutions

2.15.4 Amgen Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Amgen Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Gastrointestinal Therapeutics Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Gastrointestinal Therapeutics Players Market Share

3.2.2 Top 10 Gastrointestinal Therapeutics Players Market Share

3.2.3 Market Competition Trend

3.3 Gastrointestinal Therapeutics Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Gastrointestinal Therapeutics Revenue and Market Share by Type (2016-2021)

4.2 Global Gastrointestinal Therapeutics Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Gastrointestinal Therapeutics Revenue Market Share by Application (2016-2021)

5.2 Gastrointestinal Therapeutics Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Gastrointestinal Therapeutics Revenue by Type (2016-2026)

6.2 North America Gastrointestinal Therapeutics Revenue by Application (2016-2026)

6.3 North America Gastrointestinal Therapeutics Market Size by Country

6.3.1 North America Gastrointestinal Therapeutics Revenue by Country (2016-2026)

6.3.2 United States Gastrointestinal Therapeutics Market Size and Forecast (2016-2026)

6.3.3 Canada Gastrointestinal Therapeutics Market Size and Forecast (2016-2026)

6.3.4 Mexico Gastrointestinal Therapeutics Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Gastrointestinal Therapeutics Revenue by Type (2016-2026)

7.2 Europe Gastrointestinal Therapeutics Revenue by Application (2016-2026)

7.3 Europe Gastrointestinal Therapeutics Market Size by Country

7.3.1 Europe Gastrointestinal Therapeutics Revenue by Country (2016-2026)

7.3.2 Germany Gastrointestinal Therapeutics Market Size and Forecast (2016-2026)

7.3.3 France Gastrointestinal Therapeutics Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Gastrointestinal Therapeutics Market Size and Forecast (2016-2026)

7.3.5 Russia Gastrointestinal Therapeutics Market Size and Forecast (2016-2026)

7.3.6 Italy Gastrointestinal Therapeutics Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Gastrointestinal Therapeutics Revenue by Type (2016-2026)

8.2 Asia-Pacific Gastrointestinal Therapeutics Revenue by Application (2016-2026)

8.3 Asia-Pacific Gastrointestinal Therapeutics Market Size by Region

8.3.1 Asia-Pacific Gastrointestinal Therapeutics Revenue by Region (2016-2026)

8.3.2 China Gastrointestinal Therapeutics Market Size and Forecast (2016-2026)

8.3.3 Japan Gastrointestinal Therapeutics Market Size and Forecast (2016-2026)

8.3.4 South Korea Gastrointestinal Therapeutics Market Size and Forecast (2016-2026)

8.3.5 India Gastrointestinal Therapeutics Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Gastrointestinal Therapeutics Market Size and Forecast (2016-2026)

8.3.7 Australia Gastrointestinal Therapeutics Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Gastrointestinal Therapeutics Revenue by Type (2016-2026)

9.2 South America Gastrointestinal Therapeutics Revenue by Application (2016-2026)

9.3 South America Gastrointestinal Therapeutics Market Size by Country

9.3.1 South America Gastrointestinal Therapeutics Revenue by Country (2016-2026)

9.3.2 Brazil Gastrointestinal Therapeutics Market Size and Forecast (2016-2026)

9.3.3 Argentina Gastrointestinal Therapeutics Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Gastrointestinal Therapeutics Revenue by Type (2016-2026)

10.2 Middle East & Africa Gastrointestinal Therapeutics Revenue by Application (2016-2026)

10.3 Middle East & Africa Gastrointestinal Therapeutics Market Size by Country

10.3.1 Middle East & Africa Gastrointestinal Therapeutics Revenue by Country (2016-2026)

10.3.2 Turkey Gastrointestinal Therapeutics Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Gastrointestinal Therapeutics Market Size and Forecast (2016-2026)

10.3.4 UAE Gastrointestinal Therapeutics Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Gastrointestinal Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Gastrointestinal Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Gastrointestinal Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Gastrointestinal Therapeutics Revenue (USD Million) by Region (2016-2021)

Table 5. Global Gastrointestinal Therapeutics Revenue Market Share by Region (2021-2026)

Table 6. AbbVie Corporate Information, Head Office, and Major Competitors

Table 7. AbbVie Major Business

Table 8. AbbVie Gastrointestinal Therapeutics Product and Solutions

Table 9. AbbVie Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Allergan Corporate Information, Head Office, and Major Competitors

Table 11. Allergan Major Business

Table 12. Allergan Gastrointestinal Therapeutics Product and Solutions

Table 13. Allergan Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 15. Johnson & Johnson Major Business

Table 16. Johnson & Johnson Gastrointestinal Therapeutics Product and Solutions

Table 17. Johnson & Johnson Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Takeda Corporate Information, Head Office, and Major Competitors

Table 19. Takeda Major Business

Table 20. Takeda Gastrointestinal Therapeutics Product and Solutions

Table 21. Takeda Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Novartis Corporate Information, Head Office, and Major Competitors

Table 23. Novartis Major Business

Table 24. Novartis Gastrointestinal Therapeutics Product and Solutions

Table 25. Novartis Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Pfizer Corporate Information, Head Office, and Major Competitors

Table 27. Pfizer Major Business

Table 28. Pfizer Gastrointestinal Therapeutics Product and Solutions

Table 29. Pfizer Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Merck Corporate Information, Head Office, and Major Competitors

Table 31. Merck Major Business

Table 32. Merck Gastrointestinal Therapeutics Product and Solutions

Table 33. Merck Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors

Table 35. F. Hoffmann-La Roche Major Business

Table 36. F. Hoffmann-La Roche Gastrointestinal Therapeutics Product and Solutions

Table 37. F. Hoffmann-La Roche Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Eli Lilly Corporate Information, Head Office, and Major Competitors

Table 39. Eli Lilly Major Business

Table 40. Eli Lilly Gastrointestinal Therapeutics Product and Solutions

Table 41. Eli Lilly Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. AstraZeneca Corporate Information, Head Office, and Major Competitors

Table 43. AstraZeneca Major Business

Table 44. AstraZeneca Gastrointestinal Therapeutics Product and Solutions

Table 45. AstraZeneca Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Procter & Gamble Corporate Information, Head Office, and Major Competitors

Table 47. Procter & Gamble Major Business

Table 48. Procter & Gamble Gastrointestinal Therapeutics Product and Solutions

Table 49. Procter & Gamble Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Tillotts Pharma Corporate Information, Head Office, and Major Competitors

Table 51. Tillotts Pharma Major Business

Table 52. Tillotts Pharma Gastrointestinal Therapeutics Product and Solutions

Table 53. Tillotts Pharma Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Takeda Corporate Information, Head Office, and Major Competitors

Table 55. Takeda Major Business

Table 56. Takeda Gastrointestinal Therapeutics Product and Solutions

Table 57. Takeda Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors

Table 59. GlaxoSmithKline Major Business

Table 60. GlaxoSmithKline Gastrointestinal Therapeutics Product and Solutions

Table 61. GlaxoSmithKline Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Amgen Corporate Information, Head Office, and Major Competitors

Table 63. Amgen Major Business

Table 64. Amgen Gastrointestinal Therapeutics Product and Solutions

Table 65. Amgen Gastrointestinal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Global Gastrointestinal Therapeutics Revenue (USD Million) by Players (2019-2021)

Table 67. Global Gastrointestinal Therapeutics Revenue Share by Players (2019-2021)

Table 68. Breakdown of Gastrointestinal Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 69. Gastrointestinal Therapeutics Players Head Office, Products and Services Provided

Table 70. Gastrointestinal Therapeutics Mergers & Acquisitions in the Past Five Years

Table 71. Gastrointestinal Therapeutics New Entrants and Expansion Plans

Table 72. Global Gastrointestinal Therapeutics Revenue (USD Million) by Type (2016-2021)

Table 73. Global Gastrointestinal Therapeutics Revenue Share by Type (2016-2021)

Table 74. Global Gastrointestinal Therapeutics Revenue Forecast by Type (2021-2026)

Table 75. Global Gastrointestinal Therapeutics Revenue by Application (2016-2021)

Table 76. Global Gastrointestinal Therapeutics Revenue Forecast by Application (2021-2026)

Table 77. North America Gastrointestinal Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 78. North America Gastrointestinal Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 79. North America Gastrointestinal Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 80. North America Gastrointestinal Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 81. North America Gastrointestinal Therapeutics Revenue by Country (2016-2021) & (USD Million)

Table 82. North America Gastrointestinal Therapeutics Revenue by Country (2021-2026) & (USD Million)

Table 83. Europe Gastrointestinal Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 84. Europe Gastrointestinal Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 85. Europe Gastrointestinal Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 86. Europe Gastrointestinal Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 87. Europe Gastrointestinal Therapeutics Revenue by Country (2016-2021) & (USD Million)

Table 88. Europe Gastrointestinal Therapeutics Revenue by Country (2021-2026) & (USD Million)

Table 89. Asia-Pacific Gastrointestinal Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 90. Asia-Pacific Gastrointestinal Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 91. Asia-Pacific Gastrointestinal Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 92. Asia-Pacific Gastrointestinal Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 93. Asia-Pacific Gastrointestinal Therapeutics Revenue by Region (2016-2021) & (USD Million)

Table 94. Asia-Pacific Gastrointestinal Therapeutics Revenue by Region (2021-2026) & (USD Million)

Table 95. South America Gastrointestinal Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 96. South America Gastrointestinal Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 97. South America Gastrointestinal Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 98. South America Gastrointestinal Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 99. South America Gastrointestinal Therapeutics Revenue by Country (2016-2021) & (USD Million)

Table 100. South America Gastrointestinal Therapeutics Revenue by Country (2021-2026) & (USD Million)

Table 101. Middle East & Africa Gastrointestinal Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 102. Middle East & Africa Gastrointestinal Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 103. Middle East & Africa Gastrointestinal Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 104. Middle East & Africa Gastrointestinal Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 105. Middle East & Africa Gastrointestinal Therapeutics Revenue by Country (2016-2021) & (USD Million)

Table 106. Middle East & Africa Gastrointestinal Therapeutics Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Gastrointestinal Therapeutics Picture

Figure 2. Global Gastrointestinal Therapeutics Revenue Market Share by Type in 2020

Figure 3. Oral

Figure 4. Parenteral

Figure 5. Gastrointestinal Therapeutics Revenue Market Share by Application in 2020

Figure 6. IBD Picture

Figure 7. Irritable Bowel Syndrome (IBS) Picture

Figure 8. Global Gastrointestinal Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 9. Global Gastrointestinal Therapeutics Revenue and Forecast (2016-2026) & (USD Million)

Figure 10. Global Gastrointestinal Therapeutics Revenue Market Share by Region (2016-2026)

Figure 11. Global Gastrointestinal Therapeutics Revenue Market Share by Region in 2020

Figure 12. North America Gastrointestinal Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 13. Europe Gastrointestinal Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 14. Asia-Pacific Gastrointestinal Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. South America Gastrointestinal Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Middle East and Africa Gastrointestinal Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Gastrointestinal Therapeutics Market Drivers

Figure 18. Gastrointestinal Therapeutics Market Restraints

Figure 19. Gastrointestinal Therapeutics Market Trends

Figure 20. AbbVie Recent Developments and Future Plans

Figure 21. Allergan Recent Developments and Future Plans

Figure 22. Johnson & Johnson Recent Developments and Future Plans

Figure 23. Takeda Recent Developments and Future Plans

Figure 24. Novartis Recent Developments and Future Plans

Figure 25. Pfizer Recent Developments and Future Plans

Figure 26. Merck Recent Developments and Future Plans

Figure 27. F. Hoffmann-La Roche Recent Developments and Future Plans

Figure 28. Eli Lilly Recent Developments and Future Plans

Figure 29. AstraZeneca Recent Developments and Future Plans

Figure 30. Procter & Gamble Recent Developments and Future Plans

Figure 31. Tillotts Pharma Recent Developments and Future Plans

Figure 32. Takeda Recent Developments and Future Plans

Figure 33. GlaxoSmithKline Recent Developments and Future Plans

Figure 34. Amgen Recent Developments and Future Plans

Figure 35. Global Gastrointestinal Therapeutics Revenue Share by Players in 2020

Figure 36. Gastrointestinal Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 37. Global Top 3 Players Gastrointestinal Therapeutics Revenue Market Share in 2020

Figure 38. Global Top 10 Players Gastrointestinal Therapeutics Revenue Market Share in 2020

Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 40. Global Gastrointestinal Therapeutics Revenue Share by Type in 2020

Figure 41. Global Gastrointestinal Therapeutics Market Share Forecast by Type (2021-2026)

Figure 42. Global Gastrointestinal Therapeutics Revenue Share by Application in 2020

Figure 43. Global Gastrointestinal Therapeutics Market Share Forecast by Application (2021-2026)

Figure 44. North America Gastrointestinal Therapeutics Sales Market Share by Type (2016-2026)

Figure 45. North America Gastrointestinal Therapeutics Sales Market Share by Application (2016-2026)

Figure 46. North America Gastrointestinal Therapeutics Revenue Market Share by Country (2016-2026)

Figure 47. United States Gastrointestinal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. Canada Gastrointestinal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Mexico Gastrointestinal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Europe Gastrointestinal Therapeutics Sales Market Share by Type (2016-2026)

Figure 51. Europe Gastrointestinal Therapeutics Sales Market Share by Application (2016-2026)

Figure 52. Europe Gastrointestinal Therapeutics Revenue Market Share by Country (2016-2026)

Figure 53. Germany Gastrointestinal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. France Gastrointestinal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. United Kingdom Gastrointestinal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Russia Gastrointestinal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Italy Gastrointestinal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Asia-Pacific Gastrointestinal Therapeutics Sales Market Share by Type (2016-2026)

Figure 59. Asia-Pacific Gastrointestinal Therapeutics Sales Market Share by Application (2016-2026)

Figure 60. Asia-Pacific Gastrointestinal Therapeutics Revenue Market Share by Region (2016-2026)

Figure 61. China Gastrointestinal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Japan Gastrointestinal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. South Korea Gastrointestinal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. India Gastrointestinal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Southeast Asia Gastrointestinal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Australia Gastrointestinal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. South America Gastrointestinal Therapeutics Sales Market Share by Type (2016-2026)

Figure 68. South America Gastrointestinal Therapeutics Sales Market Share by Application (2016-2026)

Figure 69. South America Gastrointestinal Therapeutics Revenue Market Share by Country (2016-2026)

Figure 70. Brazil Gastrointestinal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Argentina Gastrointestinal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Middle East and Africa Gastrointestinal Therapeutics Sales Market Share by Type (2016-2026)

Figure 73. Middle East and Africa Gastrointestinal Therapeutics Sales Market Share by Application (2016-2026)

Figure 74. Middle East and Africa Gastrointestinal Therapeutics Revenue Market Share by Country (2016-2026)

Figure 75. Turkey Gastrointestinal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Saudi Arabia Gastrointestinal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. UAE Gastrointestinal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Methodology

Figure 79. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz